Russell Investments Group
AMRI

Russell Investments Group’s Albany Molecular Research Inc AMRI Stock Holding History

Russell Investments Group’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-163,471
Closed -$3.55M – 3090
2017
Q2 		$3.55M Sell
163,471
-34,725
-18% -$630K 0.01% 1413
2017
Q1 		$2.78M Sell
198,196
-18,930
-9% -$310K 0.01% 1569
2016
Q4 		$4.06M Buy
+217,126
New +$3.69M 0.01% 1373

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Russell Investments Group's AMRI Position: Q3 2017 in Review

Russell Investments Group sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 163,471 shares — an estimated $3.55M sold.

Russell Investments Group first reported a position in AMRI in Q4 2016 and held it in 3 quarters. The position peaked at $4.06M in Q4 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Russell Investments Group reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Russell Investments Group sold 163,471 Albany Molecular Research Inc shares in Q3 2017, an estimated $3.55M.
  • Russell Investments Group first reported a position in Albany Molecular Research Inc in Q4 2016 and held it in 3 quarters.
  • Russell Investments Group's Albany Molecular Research Inc position peaked at $4.06M in Q4 2016.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Russell Investments Group's 13F filing for Q3 2017, filed 7 Nov 2017.